Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine vs Bupivacaine for Preemptive Analgesia in Ankle Fracture Surgery
NCT02949674Phase 3Completed
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Sep 2016
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial of ropivacaine and bupivacaine in postoperative pain (3 arms), sponsored by Instituto Mexicano del Seguro Social. Primary endpoint: Visual Analogue Scale at 24 hours. Started Sep 2016; status: completed.
02
Drugs
ropivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02949674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02949674.